Torsten Haack

1.0k citations

27 papers · 663 indexed · h-index 15

Impact in

Endocrinology, Diabetes and Metabolism top 5%
- Diabetes Treatment and Management
Pharmaceutical Science top 10%

Papers in ⓘ

Endocrinology, Diabetes and Metabolism 14
- Diabetes Treatment and Management 13
Cellular and Molecular Neuroscience 6
- Neuropeptides and Animal Physiology 6

Co-authors: Michael Wagner (15 shared papers)Martin Bossart (13 shared papers)Philip J. Larsen (8 shared papers)Andreas Evers (9 shared papers)Gernot Boche (3 shared papers)J. Tillner (5 shared papers)Gunda I. Georg (6 shared papers)Youssef Hijazi (2 shared papers)
Journals: Diabetes Obesity and Metabolism (3 papers)Scientific Reports (2 papers)Organic Letters (2 papers)Mutation Research/Genetic Toxicology and Environmental Mutagenesis (2 papers)Journal of Nuclear Medicine (2 papers)
Partner nations: Germany United States Sweden

In The Last Decade

Torsten Haack

27 papers receiving 647 citations

Peers

Countries citing papers authored by Torsten Haack

Since Specialization

Citations

This map shows the geographic impact of Torsten Haack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torsten Haack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torsten Haack more than expected).

Fields of papers citing papers by Torsten Haack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torsten Haack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torsten Haack. The network helps show where Torsten Haack may publish in the future.

Co-authors

The 25 scholars most cited alongside Torsten Haack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Torsten Haack Line = papers co-authored together Torsten Haack links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A novel dual glucagon‐like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo‐controlled first‐in‐human and first‐in‐patient trials Diabetes Obesity and Metabolism ·J. Tillner, Maximilian Posch, Frank Wagner, Lenore Teichert, Youssef Hijazi, Christine Einig, Stefanie Keil, Torsten Haack, Michael Wagner, Martin Bossart, Philip J. Larsen	2018	135
2	Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Journal of Medicinal Chemistry ·Andreas Evers, Torsten Haack, M. Lorenz, Martin Bossart, Ralf Elvert, Bernd Henkel, Siegfried Stengelin, Michael Kurz, Maike Glien, Angela Dudda, Katrin Lorenz, Dieter Kadereit, Michael Wagner	2017	89
3	Oral delivery of diabetes peptides — Comparing standard formulations incorporating functional excipients and nanotechnologies in the translational context Advanced Drug Delivery Reviews ·Harivardhan Reddy Lakkireddy, Matthias Urmann, Melissa Besenius, Werner Ulrich, Torsten Haack, Priscilla Brun, Jean Alié, Brigitte Illel, Laurent Hortala, Rachel Vogel, Didier Bazile	2016	56
4	Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations Journal of Medicinal Chemistry ·Andreas Evers, Martin Bossart, Stefania Pfeiffer‐Marek, Ralf Elvert, Herman Schreuder, Michael Kurz, Siegfried Stengelin, M. Lorenz, Andreas W. Herling, Anish Konkar, Ulrike Lukasczyk, Anja Pfenninger, Katrin Lorenz, Torsten Haack, Dieter Kadereit, Michael Wagner	2018	40
5	Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes Scientific Reports ·Olof Eriksson, Torsten Haack, Youssef Hijazi, Lenore Teichert, Veronique Tavernier, Iina Laitinen, Jan Erik Berglund, Gunnar Antoni, Irina Velikyan, L. E. B. Johansson, Stefan Pierrou, Michael Wagner, J. Tillner	2020	34
6	Incretin combination therapy for the treatment of non‐alcoholic steatohepatitis Diabetes Obesity and Metabolism ·Aimo Kannt, Andreas Nygaard Madsen, Claire Kammermeier, Ralf Elvert, Tim Klöckener, Martin Bossart, Torsten Haack, Andreas Evers, Katrin Lorenz, Wolfgang Hennerici, Corinne Rocher, Zsolt Böcskei, Jean‐Claude Guillemot, Vincent Mikol, François Pattou, Bart Staels, Michael Wagner	2020	33
7	Running on mixed fuel‐dual agonistic approach of GLP‐1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non‐human primates Diabetes Obesity and Metabolism ·Ralf Elvert, Andreas W. Herling, Martin Bossart, Tilo Weiß, Baohong Zhang, Pierre Wenski, Jörn Wandschneider, Sabrina Kleutsch, Uwe Butty, Aimo Kannt, Michael Wagner, Torsten Haack, Andreas Evers, Angela Dudda, M. Lorenz, Stefanie Keil, Philip J. Larsen	2018	30
8	Mutagenicity in Salmonella typhimurium TA98 and TA100 of nitroso and respective hydroxylamine compounds Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Torsten Haack, Lothar Erdinger, Gernot Boche	2001	29
9	Synthesis of a quinolone library from ynones Tetrahedron Letters ·Timothy R. Ward, Brandon J. Turunen, Torsten Haack, Benjamin Neuenswander, William R. Shadrick, Gunda I. Georg	2009	27
10	From mutagenic to non-mutagenic nitroarenes: effect of bulky alkyl substituents on the mutagenic activity of 4-nitrobiphenyl in Salmonella typhimurium Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Markus Klein, Ulrike Voigtmann, Torsten Haack, Lothar Erdinger, Gernot Boche	2000	26
11	1,1-Dioxo-5,6-dihydro-[4,1,2]oxathiazines, a novel class of 11ß-HSD1 inhibitors for the treatment of diabetes Bioorganic & Medicinal Chemistry Letters ·Thomas Böhme, Christian K. Engel, Géraldine Farjot, Stefan Güssregen, Torsten Haack, Georg Tschank, Kurt Ritter	2013	19
12	Team Players or Opponents: Coadministration of Selective Glucagon and GLP-1 Receptor Agonists in Obese Diabetic Monkeys Endocrinology ·Ralf Elvert, Martin Bossart, Andreas W. Herling, Tilo Weiß, Baohong Zhang, Aimo Kannt, Michael Wagner, Torsten Haack, Andreas Evers, Angela Dudda, Stefanie Keil, M. Lorenz, Katrin Lorenz, Michela Riz, Wolfgang Hennerici, Philip J. Larsen	2018	19
13	First-in-class positron emission tomography tracer for the glucagon receptor EJNMMI Research ·Irina Velikyan, Torsten Haack, Martin Bossart, Andreas Evers, Iina Laitinen, Philip J. Larsen, Oliver Plettenburg, L. E. B. Johansson, Stefan Pierrou, Michael Wagner, Olof Eriksson	2019	18
14	Studies toward the Synthesis of Oximidines I and II Organic Letters ·Torsten Haack, Serdar Kurtkaya, James P. Snyder, Gunda I. Georg	2003	16
15	Synthesis of Oximidine II by a Copper‐Mediated Reductive Ene–Yne Macrocyclization Angewandte Chemie International Edition ·Christopher Schneider, Kriangsak Khownium, Wei Li, Jared T. Spletstoser, Torsten Haack, Gunda I. Georg	2011	15
16	Enantiospecific Formal Total Syntheses of (−)-Salicylihalamides A and B from d-Glucose and l-Rhamnose Organic Letters ·KyoungLang Yang, Torsten Haack, Burchelle Blackman, Wibke E. Diederich, Shibendu Shekhar Roy, Srinivas Pusuluri, Gunda I. Georg	2003	11
17	Formal Total Syntheses of the (−)-Salicylihalamides A and B From d-Glucose and l-Rhamnose The Journal of Organic Chemistry ·Torsten Haack, KyoungLang Haack, Wibke E. Diederich, Burchelle Blackman, Shibendu Shekhar Roy, Srinivas Pusuluri, Gunda I. Georg	2005	11
18	Imaging of the Glucagon Receptor in Subjects with Type 2 Diabetes Journal of Nuclear Medicine ·Olof Eriksson, Irina Velikyan, Torsten Haack, Martin Bossart, Iina Laitinen, Philip J. Larsen, Jan Erik Berglund, Gunnar Antoni, L. E. B. Johansson, Stefan Pierrou, J. Tillner, Michael Wagner	2020	8
19	Drug Occupancy Assessment at the Glucose-Dependent Insulinotropic Polypeptide Receptor by Positron Emission Tomography Diabetes ·Olof Eriksson, Irina Velikyan, Torsten Haack, Martin Bossart, Andreas Evers, Katrin Lorenz, Iina Laitinen, Philip J. Larsen, Oliver Plettenburg, L. E. B. Johansson, Stefan Pierrou, Michael Wagner	2021	8
20	Assessment of glucagon receptor occupancy by Positron Emission Tomography in non-human primates Scientific Reports ·Olof Eriksson, Irina Velikyan, Torsten Haack, Martin Bossart, Andreas Evers, Iina Laitinen, Philip J. Larsen, Oliver Plettenburg, Akihiro Takano, Christer Halldin, Gunnar Antoni, L. E. B. Johansson, Stefan Pierrou, Michael Wagner	2019	7

About Torsten Haack

Torsten Haack is a scholar working on Endocrinology, Diabetes and Metabolism, Cellular and Molecular Neuroscience, Endocrine and Autonomic Systems, Toxicology and Organic Chemistry, having authored 27 papers that have together received 663 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (13 papers), Neuropeptides and Animal Physiology (6 papers), Receptor Mechanisms and Signaling (6 papers), Synthetic Organic Chemistry Methods (4 papers), Pancreatic function and diabetes (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Neuroendocrine Tumor Research Advances (3 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (358 citations), Pharmaceutical Science (47 citations), Pharmacology (115 citations), Endocrine and Autonomic Systems (40 citations) and Cellular and Molecular Neuroscience (93 citations). Torsten Haack has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Michael Wagner, Martin Bossart, Philip J. Larsen, Andreas Evers, Gernot Boche, J. Tillner, Gunda I. Georg, Youssef Hijazi, Stefanie Keil and Lenore Teichert. Their work appears in journals such as Diabetes Obesity and Metabolism, Scientific Reports, Organic Letters, Mutation Research/Genetic Toxicology and Environmental Mutagenesis and Journal of Nuclear Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact